Chen-yang He

Chengdu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Could the cognitive benefits of amyloid-beta clearance grow in time for Alzheimer's disease?

Could the cognitive benefits of amyloid-beta clearance grow in time for Alzheimer's disease?

Journal: Translational psychiatry

Published: January 23, 2026

Associations Between Plasma Klotho with Renal Function and Cerebrospinal Fluid Amyloid-β Levels in Alzheimer's Disease: The Chongqing Ageing & Dementia Study.

Associations Between Plasma Klotho with Renal Function and Cerebrospinal Fluid Amyloid-β Levels in Alzheimer's Disease: The Chongqing Ageing & Dementia Study.

Journal: Journal of Alzheimer's disease : JAD

Published: February 13, 2023

Physiological β-amyloid clearance by the liver and its therapeutic potential for Alzheimer's disease.

Physiological β-amyloid clearance by the liver and its therapeutic potential for Alzheimer's disease.

Journal: Acta neuropathologica

Published: January 09, 2023

The Correlations of Plasma Liver-Type Fatty Acid-Binding Protein with Amyloid-β and Tau Levels in Patients with Alzheimer's Disease.

The Correlations of Plasma Liver-Type Fatty Acid-Binding Protein with Amyloid-β and Tau Levels in Patients with Alzheimer's Disease.

Journal: Journal of Alzheimer's disease : JAD

Published: May 23, 2022

Association of rs2072446 in the NGFR gene with the risk of Alzheimer's disease and amyloid-β deposition in the brain.

Association of rs2072446 in the NGFR gene with the risk of Alzheimer's disease and amyloid-β deposition in the brain.

Journal: CNS neuroscience & therapeutics

Published: March 18, 2022

Elevated Levels of Naturally-Occurring Autoantibodies Against the Extracellular Domain of p75NTR Aggravate the Pathology of Alzheimer's Disease.

Elevated Levels of Naturally-Occurring Autoantibodies Against the Extracellular Domain of p75NTR Aggravate the Pathology of Alzheimer's Disease.

Journal: Neuroscience bulletin

Published: March 01, 2022

Associations of plasma angiostatin and amyloid-β and tau levels in Alzheimer's disease.

Associations of plasma angiostatin and amyloid-β and tau levels in Alzheimer's disease.

Journal: Translational psychiatry

Published: December 11, 2021

Naturally-Occurring Antibodies Against Bim are Decreased in Alzheimer's Disease and Attenuate AD-type Pathology in a Mouse Model.

Naturally-Occurring Antibodies Against Bim are Decreased in Alzheimer's Disease and Attenuate AD-type Pathology in a Mouse Model.

Journal: Neuroscience bulletin

Published: October 08, 2021

Dynamic changes of CSF sPDGFRβ during ageing and AD progression and associations with CSF ATN biomarkers.

Dynamic changes of CSF sPDGFRβ during ageing and AD progression and associations with CSF ATN biomarkers.

Journal: Molecular neurodegeneration

Published: September 28, 2021

Physiological clearance of Aβ by spleen and splenectomy aggravates Alzheimer-type pathogenesis.

Physiological clearance of Aβ by spleen and splenectomy aggravates Alzheimer-type pathogenesis.

Journal: Aging cell

Published: June 01, 2021

Polysaccharide Krestin Prevents Alzheimer's Disease-type Pathology and Cognitive Deficits by Enhancing Monocyte Amyloid-β Processing.

Polysaccharide Krestin Prevents Alzheimer's Disease-type Pathology and Cognitive Deficits by Enhancing Monocyte Amyloid-β Processing.

Journal: Neuroscience bulletin

Published: April 02, 2021

Physiological clearance of amyloid-beta by the kidney and its therapeutic potential for Alzheimer's disease.

Physiological clearance of amyloid-beta by the kidney and its therapeutic potential for Alzheimer's disease.

Journal: Molecular psychiatry

Published: October 13, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026